The article responds to feedback from Huang et al. regarding a study on the interplay between fibroblasts and vascular cells in pulmonary fibrosis and its connection to pulmonary hypertension. Topics include the diverse role of tacrolimus in immune modulation, its potential impact on BMPR2 signaling in treating pulmonary fibrosis-induced pulmonary hypertension.